Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fever	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Details	O
obtained	O
from	O
___	O
note.	O
Also	O
obtained	O
history	O
from	O
wife	B-Lives_alone
and	O
daughter	O
which	O
corroborates	O
story	O
below.	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
___	O
male	O
with	O
a	O
pmh	O
of	O
frontotemporal	O
dementia,	B-Dementia
parkinsonism,	O
paranoid	O
schizophrenia,	O
GERD,	O
and	O
chronic	O
Hep	O
C	O
who	O
presented	O
from	O
___	O
with	O
recurrent	O
fevers	O
since	O
___	O
without	O
a	O
clear	O
source.	O
He	O
has	O
become	O
more	O
weak,	O
and	O
decreased	O
in	O
mobility.	O
He	O
had	O
mild	O
resp	O
symptoms	O
with	O
a	O
weak	O
cough:	O
Chest	B-Lower_respiratory_tract_infection
X-ray	B-Lower_respiratory_tract_infection
negative	B-Lower_respiratory_tract_infection
(concern	O
for	O
ongoing	O
aspiration,	O
and	O
new	O
inability	O
to	O
chew	O
his	O
food).	O
CBC	O
with	O
WBC	O
of	O
11.	O
UA	O
benign	O
per	O
report.	O
Flu	O
swab	O
was	O
negative	O
and	O
he	O
was	O
empirically	O
treated	O
with	O
Tamiflu.	O
Yesterday	O
he	O
was	O
given	O
one	O
dose	O
of	O
Levaquin	O
500	O
mg	O
empirically,	O
but	O
today	O
remained	O
febrile	O
to	O
102	O
rectally.	O
Baseline	O
status	O
with	O
very	O
diminished:	O
difficulties	O
with	O
mobility,	O
needs	O
to	O
be	O
fed,	O
could	O
walk	O
with	O
assistance	B-Mobile_with_assistance
from	O
his	O
room	O
to	O
the	O
dining	O
room,	O
but	O
stopped	O
about	O
3	O
weeks	O
ago	O
per	O
CAN.	O
He	O
can	O
barely	O
answer	O
___	O
questions,	O
with	O
yes	O
or	O
no	O
at	O
baseline.	O
He	O
is	O
stiff,	O
immobile	B-Bed_Chairbound
most	O
times,	O
and	O
incontinent.	O
Chest	O
X-ray	O
stat	O
today:	O
FINDINGS:	O
One	O
portable	O
view.	O
Comparison	O
with	O
the	O
previous	O
study	O
done	O
___.	O
Lung	O
volumes	O
are	O
low	O
and	O
there	O
is	O
motion	O
artifact.	O
Minimal	O
streaky	O
density	O
at	O
the	O
lung	O
bases	O
consistent	O
with	O
subsegmental	O
atelectasis	O
persists.	O
The	O
lungs	O
appear	O
otherwise	O
clear.	O
The	O
heart	O
and	O
mediastinal	O
structures	O
are	O
unchanged.	O
The	O
bony	O
thorax	O
is	O
grossly	O
intact.	O
IMPRESSION:	O
Limited	O
study	O
demonstrating	O
no	O
acute	O
change.	O
In	O
the	O
ED,	O
initial	O
vitals:	O
100	O
99	O
130/89	O
28	O
96%	O
2L	O
Nasal	O
Cannula.	O
Temperature	O
reached	O
as	O
high	O
as	O
103.1.	O
He	O
was	O
given	O
tylenol,	O
Cipro,	O
and	O
a	O
foley	O
was	O
placed.	O
A	O
head	O
CT	O
and	O
CXR	O
were	O
performed	O
and	O
were	O
unremarkable.	O
Vitals	O
prior	O
to	O
transfer:	O
99.9	O
88	O
123/84	O
26	O
95%	O
Currently,	O
he	O
is	O
rigid.	O
Tracking	O
me	O
with	O
his	O
eyes	O
around	O
the	O
room.	O
Mouth	O
open.	O
Non	O
conversant.	O
ROS:	O
unable	O
to	O
obtain.	O
Past	O
Medical	O
History:	O
Parkinsonism	O
(failed	O
trial	O
of	O
sinemet)	O
Insomnia	O
Chronic	O
Hepatitis	O
C	O
BPH	O
Senile	O
depressive	O
disorder	O
Asthma	O
GERD	O
Aspiration	O
(chronic)	O
Frontotemporal	O
dementia	B-Dementia
Paranoid	O
Schizophrenia	O
Social	O
History:	O
___	O
Family	O
History:	O
Not	O
pertinent	O
to	O
this	O
hospitalization.	O
Physical	O
Exam:	O
Admission:	O
VS	O
-	O
Temp	O
99.4F,	O
BP	O
129/82,	O
HR	O
87,	O
R	O
18,	O
O2-sat	O
98%	O
2L	O
GENERAL	O
-	O
NAD	O
tracking,	O
but	O
not	O
moving.	O
Not	O
following	O
commands	O
HEENT	O
-	O
NC/AT,	O
PERRLA,	O
EOMI,	O
dry	O
MM,	O
mouth	O
agape,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
no	O
thyromegaly,	O
no	O
JVD	O
HEART	O
-	O
PMI	O
non-displaced,	O
RRR,	O
nl	O
S1-S2,	O
no	O
MRG	O
LUNGS	O
-	O
CTAB,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored,	O
no	O
accessory	O
muscle	O
use	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
2+	O
peripheral	O
pulses	O
(radials,	O
DPs)	O
warm	O
peripherally	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
Tracking	O
with	O
eyes,	O
downgoing	O
babinski,	O
1+	O
reflexes	O
in	O
the	O
biceps	O
and	O
patella,	O
cogwheeling	O
in	O
the	O
upper	O
extremities,	O
and	O
increased	O
tone	O
in	O
the	O
lower	O
extremities.	O
Masked	O
facies.	O
Discharge:	O
VS	O
-	O
Tm	O
/Tc	O
97.6F,	O
BP	O
106/67,	O
HR	O
81,	O
R	O
18,	O
O2-sat	O
98%	O
2L	O
GENERAL	O
-	O
NAD	O
tracking,	O
but	O
not	O
moving.	O
Not	O
following	O
commands	O
HEENT	O
-	O
NC/AT,	O
PERRLA,	O
EOMI,	O
dry	O
MM,	O
mouth	O
agape,	O
OP	O
clear	O
NECK	O
-	O
supple,	O
no	O
thyromegaly,	O
no	O
JVD	O
HEART	O
-	O
PMI	O
non-displaced,	O
RRR,	O
nl	O
S1-S2,	O
no	O
MRG	O
LUNGS	O
-	O
CTAB	O
anteriorly,	O
does	O
not	O
take	O
deep	O
inspirations	O
ABDOMEN	O
-	O
NABS,	O
soft/NT/ND,	O
no	O
masses	O
or	O
HSM,	O
no	O
rebound/guarding	O
EXTREMITIES	O
-	O
WWP,	O
no	O
c/c/e,	O
2+	O
peripheral	O
pulses	O
(radials,	O
DPs)	O
warm	O
peripherally	O
SKIN	O
-	O
no	O
rashes	O
or	O
lesions	O
NEURO	O
-	O
Tracking	O
with	O
eyes,	O
downgoing	O
babinski,	O
1+	O
reflexes	O
in	O
the	O
biceps	O
and	O
patella,	O
cogwheeling	O
in	O
the	O
upper	O
extremities,	O
and	O
increased	O
tone	O
in	O
the	O
lower	O
extremities.	O
Masked	O
facies.	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
___	O
03:20PM	O
BLOOD	O
WBC-15.3*#	O
RBC-4.97	O
Hgb-16.3	O
Hct-49.9	O
MCV-100*#	O
MCH-32.8*	O
MCHC-32.7	O
RDW-12.6	O
Plt	O
___	O
___	O
03:20PM	O
BLOOD	O
Glucose-112*	O
UreaN-30*	O
Creat-1.2	O
Na-150*	O
K-3.9	O
Cl-115*	O
HCO3-25	O
AnGap-14	O
___	O
07:10AM	O
BLOOD	O
Calcium-8.3*	O
Phos-2.6*	O
Mg-2.1	O
Discharge	O
Labs:	O
___	O
07:25AM	O
BLOOD	O
WBC-9.1	O
RBC-4.17*	O
Hgb-14.2	O
Hct-41.7	O
MCV-100*	O
MCH-34.0*	O
MCHC-34.0	O
RDW-13.1	O
Plt	O
___	O
___	O
07:25AM	O
BLOOD	O
Glucose-113*	O
UreaN-23*	O
Creat-0.8	O
Na-142	O
K-3.6	O
Cl-111*	O
HCO3-23	O
AnGap-12	O
___	O
07:25AM	O
BLOOD	O
Calcium-8.2*	O
Phos-2.5*	O
Mg-2.1	O
CXR:	O
FINDINGS:	O
A	O
frontal	O
view	O
of	O
the	O
chest	O
was	O
obtained	O
portably.	O
Low	O
lung	O
volumes	O
results	O
in	O
bronchovascular	O
crowding.	O
There	O
is	O
no	O
focal	O
consolidation,	O
pleural	O
effusion	O
or	O
pneumothorax.	O
Pulmonary	O
vasculature	O
is	O
normal.	O
Heart	O
size	O
is	O
normal.	O
The	O
aorta	O
is	O
tortuous.	O
IMPRESSION:	O
No	O
acute	B-Lower_respiratory_tract_infection
cardiopulmonary	B-Lower_respiratory_tract_infection
process.	B-Lower_respiratory_tract_infection
CT	O
Head:	O
FINDINGS:	O
There	O
is	O
no	O
acute	O
intracranial	B-Intracranial_haemorrhage
hemorrhage,	B-Intracranial_haemorrhage
edema,	O
mass	O
effect	O
or	O
major	O
vascular	O
territorial	O
infarct.	O
Ventricles	O
and	O
sulci	O
are	O
more	O
prominent	O
than	O
in	O
___	O
and	O
compatible	O
with	O
global	O
age-related	O
volume	O
loss.	O
There	O
is	O
no	O
shift	O
of	O
normally	O
midline	O
structures.	O
Basal	O
cisterns	O
are	O
preserved.	O
Gray-white	O
matter	O
differentiation	O
is	O
preserved.	O
Mild	O
hypoattenuation	O
in	O
the	O
left	O
subinsular	O
region	O
is	O
likely	O
sequelae	O
of	O
chronic	O
microvascular	O
ischemic	O
disease.	O
No	O
osseous	O
abnormality	O
is	O
identified.	O
The	O
visualized	O
paranasal	O
sinuses	O
are	O
clear.	O
The	O
right	O
mastoid	O
air	O
cells	O
are	O
under	O
developed.	O
The	O
left	O
mastoid	O
air	O
cells	O
are	O
clear.	O
IMPRESSION:	O
No	O
acute	O
intracranial	B-Intracranial_haemorrhage
process.	B-Intracranial_haemorrhage
Microbiology:	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
2:20	O
pm	O
SPUTUM	O
Source:	O
Expectorated.	O
GRAM	O
STAIN	O
(Final	O
___:	O
___	O
PMNs	O
and	O
<10	O
epithelial	O
cells/100X	O
field.	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
GRAM	O
POSITIVE	O
ROD(S).	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
GRAM	O
NEGATIVE	O
ROD(S).	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
BUDDING	O
YEAST	O
WITH	O
PSEUDOHYPHAE.	O
SMEAR	O
REVIEWED;	O
RESULTS	O
CONFIRMED.	O
RESPIRATORY	O
CULTURE	O
(Preliminary):	O
Further	O
incubation	O
required	O
to	O
determine	O
the	O
presence	O
or	O
absence	O
of	O
commensal	O
respiratory	O
flora.	O
YEAST.	O
10,000-100,000	O
ORGANISMS/ML..	O
___	O
8:47	O
pm	O
STOOL	O
CONSISTENCY:	O
SOFT	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
C.	O
difficile	O
DNA	O
amplification	O
assay	O
(Final	O
___:	O
Negative	O
for	O
toxigenic	O
C.	O
difficile	O
by	O
the	O
Illumigene	O
DNA	O
amplification	O
assay.	O
(Reference	O
Range-Negative).	O
Blood	O
culture	O
x4	O
no	O
growth	O
to	O
date.	O
Final	O
pending.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
___	O
male	O
with	O
a	O
pmh	O
of	O
frontotemporal	O
dementia,	B-Dementia
parkinsonism,	O
paranoid	O
schizophrenia,	O
GERD,	O
and	O
chronic	O
Hep	O
C	O
who	O
presented	O
from	O
___	O
with	O
recurrent	O
fevers	O
since	O
___	O
without	O
a	O
clear	O
source.	O
#	O
Fever.	O
Currently	O
with	O
a	O
negative	O
work-up.	O
There	O
were	O
several	O
concerns.	O
He	O
had	O
a	O
leukocytosis	O
and	O
fever	O
to	O
103	O
in	O
the	O
ED,	O
WBCs	O
on	O
his	O
UA,	O
with	O
concern	O
for	O
chronic	O
aspiration	O
and	O
a	O
midline	O
line	O
IV	O
in	O
place	O
on	O
admission.	O
Blood,	O
lung,	O
and	O
urine	O
were	O
all	O
potential	O
sources.	O
He	O
had	O
cultures	O
sent	O
for	O
all	O
three	O
sources	O
and	O
had	O
been	O
covered	O
with	O
levo,	O
flagyl,	O
and	O
vanc	O
at	O
his	O
NH.	O
His	O
urine	O
culture	O
was	O
negative,	O
sputum	O
grew	O
yeast	O
and	O
respiratory	O
flora	O
and	O
his	O
blood	O
cultures	O
were	O
NGTD	O
at	O
discharge.	O
He	O
was	O
initially	O
covered	O
broadly	O
with	O
vanc	O
and	O
imipenem	O
out	O
of	O
concern	O
for	O
aspiration,	O
but	O
CXR	O
and	O
sputum	O
pointed	O
away	O
from	O
this.	O
He	O
was	O
narrowed	O
after	O
48	O
hours	O
to	O
Ciprofloxacin	O
and	O
remained	O
afebrile.	O
His	O
midline	O
was	O
removed.	O
#	O
Hyponatremia.	O
150	O
on	O
admission,	O
likely	O
from	O
decrease	O
in	O
PO	O
intake,	O
and	O
inability	O
to	O
access	O
free	O
water	O
with	O
increased	O
insensible	O
losses.	O
He	O
was	O
given	O
2L	O
NS	O
in	O
the	O
ED	O
and	O
Repleted	O
with	O
D5W	O
at	O
125cc/hr	O
which	O
corrected	O
his	O
sodium	O
to	O
143.	O
He	O
was	O
able	O
to	O
take	O
fluids	O
PO	O
without	O
coughing.	O
He	O
will	O
need	O
a	O
formal	O
speech	O
and	O
swallow	O
evaluation	O
to	O
determine	O
what	O
he	O
will	O
be	O
able	O
to	O
take	O
by	O
mouth	O
going	O
forward.	O
#	O
Frontotemporal	O
dementia/Parkinsonism.	B-Dementia
He	O
failed	O
a	O
trial	O
of	O
treatment	O
in	O
the	O
past	O
with	O
worsening	O
psychosis	O
on	O
antiParkinsonian	O
meds.	O
Currently	O
on	O
bupropion	O
and	O
mirtazapine	O
and	O
treating	O
insomnia	O
with	O
lorazepam.	O
#	O
Somnolence:	O
Unclear	O
etiology	O
during	O
his	O
stay.	O
He	O
had	O
waxing	O
and	O
waning	O
and	O
the	O
differential	O
included	O
hypoactive	O
delirium	O
complicated	O
by	O
acute	O
illness.	O
Also	O
likely	O
a	O
medication	O
effect.	O
He	O
had	O
received	O
metoclopramide	O
standing	O
during	O
admission.	O
This	O
was	O
discontinued	O
for	O
somnolence.	O
His	O
psychiatric	O
medications	O
were	O
also	O
held	O
for	O
1	O
dose	O
and	O
bupropion	O
was	O
halved	O
in	O
dosing	O
to	O
37.5mg	O
BID,	O
with	O
mirtazapine	O
and	O
lorazepam	O
being	O
made	O
prn	O
due	O
to	O
somnolence.	O
As	O
he	O
continues	O
to	O
clinically	O
improve	O
his	O
medications	O
can	O
be	O
uptitrated	O
as	O
he	O
tolerates	O
to	O
his	O
regular	O
dosing.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
3X/WEEK	O
(___)	O
2.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
3.	O
BuPROPion	O
75	O
mg	O
PO	O
BID	O
4.	O
Mirtazapine	O
30	O
mg	O
PO	O
HS	O
5.	O
Lorazepam	O
0.5	O
mg	O
PO	O
HS	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
sob/wheeze	O
8.	O
Guaifenesin-Dextromethorphan	O
10	O
mL	O
PO	O
Q6H:PRN	O
cough	O
9.	O
Fluticasone-Salmeterol	O
Diskus	O
(500/50)	O
1	O
INH	O
IH	O
BID	O
10.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
11.	O
Polytrim	O
*NF*	O
(trimethoprim-polymyxin	O
B)	O
0.1-10,000	O
%-unit/mL	O
___	O
BID	O
12.	O
Acetylcysteine	O
20%	O
___	O
mL	O
NEB	O
BID	O
13.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q8H	O
14.	O
Metoclopramide	O
10	O
mg	O
PO	O
TID	O
with	O
meals	O
15.	O
Levofloxacin	O
500	O
mg	O
IV	O
Q24H	O
16.	O
MetRONIDAZOLE	O
(FLagyl)	O
500	O
mg	O
IV	O
Q8H	O
17.	O
Vancomycin	O
1000	O
mg	O
IV	O
Q	O
24H	O
18.	O
Ibuprofen	O
400	O
mg	O
PO	O
Q8H:PRN	O
pain/fever	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
sob/wheeze	O
2.	O
Bisacodyl	O
10	O
mg	O
PO/PR	O
3X/WEEK	O
(___)	O
3.	O
BuPROPion	O
37.5	O
mg	O
PO	O
BID	O
4.	O
Fluticasone-Salmeterol	O
Diskus	O
(500/50)	O
1	O
INH	O
IH	O
BID	O
5.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
hold	O
for	O
SBP	O
<100,	O
HR	O
<60	O
6.	O
Mirtazapine	O
30	O
mg	O
PO	O
HS:PRN	O
insomnia	O
7.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
8.	O
Ciprofloxacin	O
400	O
mg	O
IV	O
Q12H	O
Duration:	O
4	O
Days	O
9.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q8H	O
10.	O
Acetylcysteine	O
20%	O
___	O
mL	O
NEB	O
BID	O
11.	O
Guaifenesin-Dextromethorphan	O
10	O
mL	O
PO	O
Q6H:PRN	O
cough	O
12.	O
Ibuprofen	O
400	O
mg	O
PO	O
Q8H:PRN	O
pain/fever	O
13.	O
Lorazepam	O
0.5	O
mg	O
PO	O
HS	O
14.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
15.	O
Polytrim	O
*NF*	O
(trimethoprim-polymyxin	O
B)	O
0.1-10,000	O
%-unit/mL	O
___	O
BID	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
UTI	B-Urinary_tract_infection
Frontotemporal	O
dementia	B-Dementia
___	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Eye's	O
open,	O
tracks,	O
unresponsive	O
otherwise	O
Level	O
of	O
Consciousness:	O
Alert	O
with	O
periods	O
of	O
somnolence	O
Activity	O
Status:	O
bedbound	B-Bed_Chairbound
Discharge	O
Instructions:	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
part	O
in	O
your	O
care.	O
You	O
were	O
admitted	O
to	O
___	O
for	O
fevers.	O
We	O
tested	O
your	O
sputum,	O
blood,	O
and	O
urine	B-Urinary_tract_infection
for	O
infection.	B-Urinary_tract_infection
All	O
of	O
these	O
cultures	O
were	O
negative,	O
or	O
without	O
growth	O
at	O
the	O
time	O
of	O
your	O
discharge.	O
You	O
were	O
initially	O
covered	O
with	O
broad	O
spectrum	O
antibiotics	O
for	O
fever	O
of	O
103.	O
However,	O
your	O
fevers	O
broke	O
and	O
you	O
were	O
treated	O
with	O
Ciprofloxacin,	O
and	O
you	O
will	O
require	O
7	O
days	O
total	O
of	O
antibiotics.	O
The	O
midline	O
IV	O
in	O
your	O
right	O
arm	O
was	O
discontinued	O
out	O
of	O
concern	O
that	O
this	O
was	O
the	O
source	O
of	O
your	O
infection.	O
You	O
also	O
had	O
periods	O
of	O
somnolence	O
that	O
was	O
likely	O
related	O
to	O
your	O
acute	O
illness	O
and	O
medications.	O
Followup	O
Instructions:	O
___	O

